Buscar
Mostrando ítems 1-10 de 89
Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients
(Elsevier, 2014)
In this study, 103 unrelated South-American patients with mucopolysaccharidosis type II (MPS II) were investigated aiming at the identification of iduronate-2-sulfatase (IDS) disease causing mutations and the possibility ...
Mucopolysaccharidosis type II: Identification of 30 novel mutations among Latin American patients
(Elsevier, 2014)
In this study, 103 unrelated South-American patients with mucopolysaccharidosis type II (MPS II) were investigated aiming at the identification of iduronate-2-sulfatase (IDS) disease causing mutations and the possibility ...
Mucopolysaccharidosis type II: skeletal-muscle system involvement
(Lippincott Williams & WilkinsPhiladelphiaEUA, 2010)
Laronidase for treating mucopolysaccharidosis type I
(Funpec-editora, 2007-01-01)
Mucopolysaccharidoses are a group of inherited metabolic diseases caused by the absence or deficiency of the lysosomal enzymes that are needed for breaking down glycosaminoglycans (GAGs). Over time, GAGs collect in cells, ...
Identification of 17 novel mutations in 40 Argentinean unrelated families with mucopolysaccharidosis type II (Hunter syndrome)
(Elsevier, 2014-08)
Mucopolysaccharidosis type II (MPSII) is an X-linked lysosomal storage disorder caused by deficiency of the enzyme iduronate-2-sulfatase (IDS). The human IDS gene is located in chromosome Xq28. This is the first report of ...
Mucolipidosis tipo II: comunicación de un caso
(Sociedad Médica de Santiago, 2003)